Page last updated: 2024-08-23

diltiazem and anacetrapib

diltiazem has been researched along with anacetrapib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Corr, C; De Lepeleire, I; Garg, A; Handa, N; Jin, B; Krishna, R; Maes, A; Shah, J; Van Dyck, K; Wadhwa, T; Wagner, JA	1

Trials

1 trial(s) available for diltiazem and anacetrapib

Article	Year
Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjects. Journal of clinical pharmacology, 2011, Volume: 51, Issue:3 Topics: Adolescent; Adult; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Hyperlipidemias; Linear Models; Male; Middle Aged; Oxazolidinones; Young Adult	2011

Article

Year

Effect of diltiazem, a moderate CYP3A inhibitor, on the pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein inhibitor, in healthy subjects.

Journal of clinical pharmacology, 2011, Volume: 51, Issue:3

Topics: Adolescent; Adult; Cholesterol Ester Transfer Proteins; Cytochrome P-450 CYP3A Inhibitors; Delayed-Action Preparations; Diltiazem; Drug Interactions; Enzyme Inhibitors; Female; Half-Life; Humans; Hyperlipidemias; Linear Models; Male; Middle Aged; Oxazolidinones; Young Adult

2011